icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Virtual
February 12-16, 2022
Back grey_arrow_rt.gif
 
 
 
NAFLD IS COMMON AND ASSOCIATED WITH CARDIOVASCULAR RISK IN REPRIEVE PARTICIPANTS
 
 
  CROI 2022 Feb 11-16
 
Carl J. Fichtenbaum, MD1 Heather J. Ribaudo, PhD2 , Jana Taron, MD3, Jorge Leon-Cruz, MS2, Netanya S. Utay, MD4 Ken S. Ho, MD, MSc5, Anne F. Luetkemeyer, MD6, Shobha Swaminathan, MD7, Carrie D. Johnston, MD, MSc8, Evelynne S. Fulda, BA9, Emma Kileel, MPH9, Michael T. Lu, MD, MPH10, Steven K. Grinspoon, MD9, Jordan E. Lake, MD11, and REPRIEVE Trial Investigators. 1University of Cincinnati, 2Harvard T.H. Chan School of Public Health, 3University Medical Center Freiburg, 4University of Texas Southwestern Medical Center, 5University of Pittsburgh School of Medicine, 6University of California, San Francisco, 7Rutgers New Jersey Medical School, 8Weil Cornell School of Medicine, 9Massachusetts General Hospital, 10 Harvard Medical School, 11University of Texas Health Science Center.
 
Diabetes excluded

0220221

0220222

0220223

0220224

0220225

0220226

0220227